Cellply is a startup based in Italy. Brouky records 1 investor associated with the company.
Cellply is a life sciences company that develops in vitro diagnostic platforms to support personalized cancer treatment by providing tools to guide therapy decisions. Their work focuses on diagnostics for oncology to enable more tailored patient care.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.